Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mirococept for prevention of kidney transplant injury
ISRCTN14279222Phase 2Completed
- Sponsor
- Guy's and St Thomas' NHS Foundation Trust
- Start
- Oct 2024
- Modality
- Fc-Fusion Proteins → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes
01
Overview
Phase 2, randomised, open-label trial of mirococept in kidney failure, sponsored by Guy's and St Thomas' NHS Foundation Trust. Primary endpoint: Delayed graft function. Started Oct 2024; status: completed.
02
Drugs
mirococept
03
Conditions
kidney failure
Beyond the preview
Go deeper on ISRCTN14279222.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN14279222.